Role of Greyscale and Power Doppler Sonography in Therapy Monitoring in Early Rheumatoid Arthritis (RA)

Therapy Monitoring in Early Rheumatoid Arthritis: The Role of Greyscale and Power Doppler Sonography A Prospective Study Of 20 Egyptian Rheumatoid Arthritis Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00854243

Enrollment

Registered

2009-03-03

Start date

2009-04-30

Completion date

2010-04-30

Last updated

2009-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

The purpose of this study is to evaluate the role of musculoskeletal ultrasound and power Doppler in early therapy monitoring of rheumatoid arthritis patients.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 50 Years

Healthy volunteers

Inclusion criteria

* Adults: age at disease onset \>18 years and \< 50 years * Disease duration \< 3 month * Fulfilling ARA criteria for classification of RA * DMARD naive

Exclusion criteria

* Age at diagnosis \< 18 years * Disease duration \> 3 month * Previous use of DMARDS * Previous use of biologics

Outcome results